Avacta Group plc Appoints Paul Fry as Non-Executive Director
Highly experienced pharmaceutical and biotech professional joins Avacta’s Board CAMBRIDGE, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer®…
Pharmaceuticals, Biotechnology and Life Sciences
Highly experienced pharmaceutical and biotech professional joins Avacta’s Board CAMBRIDGE, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer®…
SAN DIEGO–(BUSINESS WIRE)–#biotech–Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, today…
DUBLIN–(BUSINESS WIRE)–The “5-Hydroxytryptamine Receptor 2B – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary 5-Hydroxytryptamine…
DUBLIN–(BUSINESS WIRE)–The “Orexin Receptor Type 2 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
PhoreMost’s next-generation phenotypic screening platform, SITESEEKER, to identify novel targets for Otsuka’s therapeutics discovery programmes Programmes to initially focus on…
University of Genoa Team Presented Strong EyeArt Results at the Macula in Liguria 2020 Conference LOS ANGELES–(BUSINESS WIRE)–#ai4healthcare—Eyenuk Inc., a…
PARIS–(BUSINESS WIRE)–#Frenchtech–Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway with potential applications for…
Ranked 3rd among pharmaceutical companies for sustainable leadership Recognized for environmental sustainability, equitable pricing strategies in low- and middle-income countries,…
Daratumumab-VTd is the first regimen approved in over six years for newly diagnosed patients who are eligible for a stem…
SECOND PRIVATE PLACEMENT BRINGS TOTAL TO €1 MILLION IN JANUARY 2020 BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth…